June 2010

Agile announces research and development agreement with a multinational chemical company to screen Agile's compounds for effectiveness in agriculture. News release.

May 2010

SePRO Corporation strengthens its partnership with Agile Sciences through Board participation and equity investment News release.

April 2010

Synergistic effects between conventional antibiotics and Agile's antibiofilm agents are reported in Antimicrobial Agents and Chemotherapy. View news release.

February 2010

Agile's Technology is Presented at the Center for Biofilm Engineering Technical Advisory Conference View poster.

More News...

Agile Sciences founders John Cavanagh and Christian Melander analyze the results of anti-biofilm screening tests.

The co-founders of Agile Sciences have developed compounds that can disperse colonies of bacteria called biofilms. These compounds have applications in the areas of medicine, agriculture, and industry.

Biofilms that form in the human body are up to ten thousand times more resistant to antibiotics and immune systems than free-floating bacteria, making them very difficult to treat medically. In agriculture, every year billions of dollars of crops are lost due to the formation of biofilms. Industrial needs for effective biofilm dispersion include surface coatings and cleansing products.

Agile Sciences' technology addresses problems associated with biofilm formation through the use of proprietary non-toxic organic compounds.